Cargando…
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans
The availability of direct oral anticoagulants has caused a paradigm shift in the management of thrombosis. Rivaroxaban and apixaban are 2 direct oral anticoagulants whose target specificity is activated factor X (FXa). However, it is still not fully understood if and how xabans impact platelet func...
Autores principales: | Nehaj, Frantisek, Sokol, Juraj, Ivankova, Jela, Mokan, Michal, Kovar, Frantisek, Stasko, Jan, Mokan, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714725/ https://www.ncbi.nlm.nih.gov/pubmed/29050502 http://dx.doi.org/10.1177/1076029617734310 |
Ejemplares similares
-
Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
por: Sokol, Juraj, et al.
Publicado: (2020) -
Impact of Dabigatran Treatment on Rotation Thromboelastometry
por: Sokol, Juraj, et al.
Publicado: (2021) -
Outcomes of Patients with Newly Diagnosed Cardiac Myxoma: A Retrospective Multicentric Study
por: Nehaj, Frantisek, et al.
Publicado: (2018) -
COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria: A case report
por: Sokol, Juraj, et al.
Publicado: (2021) -
Sticky platelets syndrome in a young patient with massive pulmonary embolism
por: Darulová, Stanislava, et al.
Publicado: (2013)